CreativeOne Wealth’s Mineralys Therapeutics MLYS Stock Holding History

CreativeOne Wealth’s Portfolio MLYS Stock Details MLYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$290K	Hold	10,750	–	–	0.01%	1004
2026 Q1	$291K	Hold	10,750	–	–	0.01%	988
2025 Q4	$390K	Hold	10,750	–	–	0.01%	866
2025 Q3	$408K	Hold	10,750	–	–	0.01%	839
2025 Q2	$145K	Hold	10,750	–	–	﹤0.01%	1082
2025 Q1	$171K	Hold	10,750	–	–	0.01%	1012
2024 Q4	$132K	Hold	10,750	–	–	﹤0.01%	1034
2024 Q3	$130K	Hold	10,750	–	–	﹤0.01%	923
2024 Q2	$126K	Hold	10,750	–	–	0.01%	747
2024 Q1	$139K	Hold	10,750	–	–	0.01%	855
2023 Q4	$92K	Buy	+10,750	New	+$84.4K	0.01%	611

Other funds holding MLYS

Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CreativeOne Wealth's MLYS Position: Q2 2026 in Review

CreativeOne Wealth held its Mineralys Therapeutics (MLYS) position steady in Q2 2026 at 10,750 shares worth $290K. The position accounts for 0.01% of the portfolio, ranked #1004.

CreativeOne Wealth first reported a position in MLYS in Q4 2023 and has held it in 11 quarters since. The position peaked at $408K in Q3 2025. 226 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

CreativeOne Wealth held 10,750 shares of Mineralys Therapeutics worth $290K as of Q2 2026.
CreativeOne Wealth left its Mineralys Therapeutics share count unchanged in Q2 2026.
Mineralys Therapeutics made up 0.01% of CreativeOne Wealth's portfolio in Q2 2026, its #1004 holding.
CreativeOne Wealth first reported a position in Mineralys Therapeutics in Q4 2023 and has held it in 11 quarters since.
CreativeOne Wealth's Mineralys Therapeutics position peaked at $408K in Q3 2025.
226 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on CreativeOne Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.